Toth Financial Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-20
Closed -$1.46K 802
2023
Q3
$1.46K Hold
20
﹤0.01% 678
2023
Q2
$1.66K Hold
20
﹤0.01% 660
2023
Q1
$1.52K Hold
20
﹤0.01% 700
2022
Q4
$1.66K Hold
20
﹤0.01% 611
2022
Q3
$2K Buy
+20
New +$1.69K ﹤0.01% 662
2022
Q2
Sell
-30
Closed -$3K 781
2022
Q1
$3K Buy
+30
New +$2.77K ﹤0.01% 603
2021
Q2
Sell
-125
Closed -$17K 748
2021
Q1
$17K Buy
+125
New +$18.7K ﹤0.01% 409
2019
Q2
Sell
-800
Closed -$72K 483
2019
Q1
$72K Buy
800
+100
+14% +$8.51K 0.02% 191
2018
Q4
$50K Sell
700
-300
-30% -$24.2K 0.01% 185
2018
Q3
$96K Hold
1,000
0.02% 180
2018
Q2
$95K Buy
1,000
+300
+43% +$27.6K 0.02% 177
2018
Q1
$61K Hold
700
0.01% 202
2017
Q4
$59K Buy
+700
New +$58.6K 0.01% 200
2016
Q1
Sell
-7,600
Closed -$534K 117
2015
Q4
$534K Buy
+7,600
New +$518K 0.18% 87

Other funds holding XBI

Toth Financial Advisory's XBI Position: Q4 2023 in Review

Toth Financial Advisory sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2023, closing a stake of 20 shares — an estimated $1.46K sold.

Toth Financial Advisory first reported a position in XBI in Q4 2015 and held it in 14 quarters. The position peaked at $534K in Q4 2015. 745 funds tracked by Wall St. Rank hold XBI as of Q4 2023.

  • Toth Financial Advisory reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2023 after selling out during the quarter.
  • Toth Financial Advisory sold 20 State Street SPDR S&P Biotech ETF shares in Q4 2023, an estimated $1.46K.
  • Toth Financial Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q4 2015 and held it in 14 quarters.
  • Toth Financial Advisory's State Street SPDR S&P Biotech ETF position peaked at $534K in Q4 2015.
  • 745 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2023.

Based on Toth Financial Advisory's 13F filing for Q4 2023, filed 26 Jan 2024.